A Counterfeit Drug Treaty: Great Idea, Wrong Implementation

The Lancet, Vol. 376, pp. 1446-1448, July 2010

3 Pages Posted: 10 Aug 2011

See all articles by Amir Attaran

Amir Attaran

University of Ottawa - Department of Epidemiology and Community Medicine; University of Ottawa - Common Law Section

Roger Bate

American Enterprise Institute (AEI)

Date Written: 2010

Abstract

On November 25, in Istanbul, Turkey, Ministers of Justice from Europe and around the world will meet. Many will attend to sign up to the Council of Europe’s MEDICRIME Convention, a proposed treaty to criminalise the manufacture and trade in counterfeited drugs and other medical products. The intent behind this treaty is good, but the wording creates serious difficulties, and European officials lack credibility to pursue this treaty globally as they would like. Only a treaty initiated by WHO will suffice.

Suggested Citation

Attaran, Amir and Bate, Roger, A Counterfeit Drug Treaty: Great Idea, Wrong Implementation (2010). The Lancet, Vol. 376, pp. 1446-1448, July 2010, Available at SSRN: https://ssrn.com/abstract=1907896

Amir Attaran (Contact Author)

University of Ottawa - Department of Epidemiology and Community Medicine ( email )

451 Smyth Road
Ottawa, Ontario K1H 8M5
Canada

University of Ottawa - Common Law Section ( email )

57 Louis Pasteur Street
Ottawa, K1N 6N5
Canada
613-562-5800 ext: 2015 (Phone)
613-562-5659 (Fax)

Roger Bate

American Enterprise Institute (AEI) ( email )

1150 17th Street, N.W.
Washington, DC 20036
United States

Here is the Coronavirus
related research on SSRN

Paper statistics

Downloads
130
Abstract Views
900
rank
239,127
PlumX Metrics